PolyPid Ltd. (PYPD)
After hours:
| Previous close | 4.4900 |
| Open | 4.5000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 4.4000 - 4.5000 |
| 52-week range | 3.5660 - 13.5000 |
| Volume | |
| Avg. volume | 3,349 |
| Market cap | 21.108M |
| Beta (5Y monthly) | 1.41 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -16.9900 |
| Earnings date | 08 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 12.33 |
GlobeNewswirePolyPid to Participate in Barclays 26th Annual Global Healthcare Conference
PETACH TIKVA, Israel, Feb. 28, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that Company management will participate in a fireside chat at the Barclays 26th Annual Global Healthcare Conference taking place in Miami Beach, FL, March 12 – 14, 2024. Barclays 26th Annual Global Healthcare Conference Fireside Chat Date: Thursday, March 14, 2024Time:7:30 – 7:55 AM ET The PolyPid m
ZacksPolyPid Ltd. (PYPD) Upgraded to Buy: What Does It Mean for the Stock?
PolyPid Ltd. (PYPD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Insider MonkeyPolyPid Ltd. (NASDAQ:PYPD) Q4 2023 Earnings Call Transcript
PolyPid Ltd. (NASDAQ:PYPD) Q4 2023 Earnings Call Transcript February 14, 2024 PolyPid Ltd. misses on earnings expectations. Reported EPS is $-3.97 EPS, expectations were $-2.17. PolyPid Ltd. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greeting morning and welcome to […]
